VKH
ZSAN

Virtu KCG Holdings’s Zosano Pharma Corporation ZSAN Stock Holding History

Virtu KCG Holdings’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-65
Closed -$35K – 3949
2016
Q4 		$35K Buy
+65
New +$32K ﹤0.01% 3164

Other funds holding ZSAN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Virtu KCG Holdings's ZSAN Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Zosano Pharma Corporation (ZSAN) in Q1 2017, closing a stake of 65 shares — an estimated $35K sold.

Virtu KCG Holdings first reported a position in ZSAN in Q4 2016 and held it in 1 quarter. The position peaked at $35K in Q4 2016. 26 funds tracked by Wall St. Rank hold ZSAN as of Q1 2017.

  • Virtu KCG Holdings reported no remaining Zosano Pharma Corporation position as of Q1 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 65 Zosano Pharma Corporation shares in Q1 2017, an estimated $35K.
  • Virtu KCG Holdings first reported a position in Zosano Pharma Corporation in Q4 2016 and held it in 1 quarter.
  • Virtu KCG Holdings's Zosano Pharma Corporation position peaked at $35K in Q4 2016.
  • 26 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.